Design and analysis of post-marketing research

被引:3
|
作者
Zhou, Xiao-Hua [1 ,2 ,3 ]
Wei, Yang [4 ]
机构
[1] Univ Washington, Sch Publ Hlth, Dept Biostat, Seattle, WA 98195 USA
[2] Renmin Univ China, Sch Stat, Beijing 100872, Peoples R China
[3] VA Seattle Med Ctr, Biostat Unit, Seattle, WA USA
[4] China Acad Chinese Med Sci, Inst Basic Res Clin Med, Beijing 100700, Peoples R China
关键词
traditional Chinese medicine post-marketing research; safety surveillance; pharmacovigilance methods; propensity score; ADJUSTMENT;
D O I
10.1007/s11655-013-1501-z
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
A post-marketing study is an integral part of research that helps to ensure a favorable risk-benefit profile for approved drugs used in the market. Because most of post-marketing studies use observational designs, which are liable to confounding, estimation of the causal effect of a drug versus a comparative one is very challenging. This article focuses on methodological issues of importance in designing and analyzing studies to evaluate the safety of marketed drugs, especially marketed traditional Chinese medicine (TCM) products. Advantages and limitations of the current designs and analytic methods for postmarketing studies are discussed, and recommendations are given for improving the validity of postmarketing studies in TCM products.
引用
收藏
页码:488 / 493
页数:6
相关论文
共 50 条
  • [31] Post-Marketing Drug Withdrawals: A Review
    Nutan Rao
    Roshani Powar
    Pharmaceutical Chemistry Journal, 2023, 57 : 1138 - 1146
  • [32] Optimization of the post-marketing surveillance procedure
    Kalle, Parminder
    ANNALES DE BIOLOGIE CLINIQUE, 2017, 75 (02) : 125 - 127
  • [33] POST-MARKETING SURVEILLANCE - DRUG EPIDEMIOLOGY
    BORDEN, EK
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 1981, 9 (06) : 401 - 407
  • [34] Post-marketing surveillance of novel foods
    Warner, JO
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2002, 13 (06) : 385 - 385
  • [35] Toxicity spectrum of taxanes: a safety analysis from pre-marketing to post-marketing
    Zhao, Qiuling
    Nian, Zilin
    He, Yimin
    Lai, Lijun
    Liu, Wenbin
    Huang, Shengqiang
    Yang, Lin
    EXPERT OPINION ON DRUG SAFETY, 2025,
  • [36] Response to "Post-marketing strategies for medicine''
    Goldhammer, A.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2008, 83 (01) : 25 - 25
  • [37] Post-Marketing Drug Withdrawals: A Review
    Rao, Nutan
    Powar, Roshani
    PHARMACEUTICAL CHEMISTRY JOURNAL, 2023, 57 (07) : 1138 - 1146
  • [38] Post-marketing device safety surveillance
    Vidi, Venkatesan D.
    Matheny, Michael E.
    Resnic, Frederic S.
    CONTEMPORARY CLINICAL TRIALS, 2011, 32 (03) : 307 - 308
  • [40] Post-marketing stability surveillance: Amoxicillin
    Naidoo, K. K.
    Nompuku, P.
    Mkalali, S. N.
    Shabangu, K.
    Nkabinde, L.
    Singh, V
    SOUTH AFRICAN FAMILY PRACTICE, 2006, 48 (06) : 14 - +